Vktx nasdaq.

A high-level overview of Viking Therapeutics, Inc. (VKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment ofFind the latest Financials data for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. Find the latest press releases from Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. Nasdaq Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access ...

Shares of NASDAQ VKTX opened at $13.01 on Monday. Viking Therapeutics has a 12 month low of $3.54 and a 12 month high of $25.72. The stock has a 50 day moving average of $10.86 and a 200-day ...

Nasdaq Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access ...

VKTX Viking Therapeutics Inc Viking Therapeutics to Present at SVB Securities Global Biopharma ConferenceSAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...VKTX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. VIKING THERAPEUTICS, INC. (VKTX) Compare. VIKING THERAPEUTICS, INC. 15.39 ...Please enter a valid Stock, ETF, Mutual Fund, or index symbol. Recent research: Viking Therapeutics Inc. Viking Therapeutics Inc VKTX:NASDAQ. Last Price ...In the last 3 months, 9 analysts have offered 12-month price targets for Viking Therapeutics. The company has an average price target of $33.0 with a high of $40.00 and a low of $24.00. Below is a ...

Standing squarely in the bull camp, BTIG analyst Justin Zelin rates VKTX a Buy along with a $20 price target. This target puts the upside potential at a whopping 221%. This target puts the upside ...

Find the latest Earnings Report Date for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.

Shares of Viking Therapeutics ( VKTX 6.23%) were up 89.7% for the week as of Thursday afternoon, after being up as much as 95.5% for the week, according to data provided by S&P Global Market ...NASDAQ: VKTX Viking Therapeutics. Market Cap. $1B. Today's Change (1.85%) $0.21. Current Price. $11.56. ... (VKTX 1.85%) are down about 25% from the peak they reached in mid-March. If you weren't ...Nov 30, 2023 · The latest price target for Viking Therapeutics ( NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023. The analyst firm set a price target for 32.00 expecting VKTX to rise ... The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on December 4, 2023.The analyst firm set a price target for $32.00 expecting VKTX to rise to within ...Viking Therapeutics Inc (NASDAQ:VKTX) 13.01 Delayed Data As of Dec 01 +0.79 / +6.42% Today’s Change 3.54 Today ||| 52-Week Range 25.72 +38.35% Year-to-Date Quote Profile News Charts Forecasts...Clinical-stage biotech Viking Therapeutics (NASDAQ:VKTX) added ~39% pre-market Tuesday after announcing that its obesity candidate VK2735 led to an average body weight reduction of up to ~8% in a ...

Since the year began, shares of Viking Therapeutics (NASDAQ:VKTX) exploded from about $8 to about $25 a share.All thanks to its potential treatment for obesity, VK2735. So far, we know it works ...Find the latest Earnings Report Date for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. Viking Therapeutics, Inc. (VKTX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 13.01 +0.79 (+6.46%) At close: 04:00PM EST 13.10 +0.09 (+0.69%) After hours: 07:47PM EST...Find real-time VKTX - Viking Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.EPS Estimate Trends. Current. N/A. 1 Month Ago. -$0.24. 3 Months Ago. -$0.24. Viking Therapeutics Inc. analyst estimates, including VKTX earnings per share estimates and analyst recommendations.

As of February 3, 2023, the average one-year price target for Viking Therapeutics is $18.70. The forecasts range from a low of $11.11 to a high of $31.50. The average price target represents an ...

Viking Therapeutics (NASDAQ:VKTX) is a great speculative biotech play to look into. The reason why I state that is because I believe it has huge potential as a long-term play.Since the year began, shares of Viking Therapeutics (NASDAQ:VKTX) exploded from about $8 to about $25 a share. All thanks to its potential treatment for obesity, VK2735. All thanks to its ...Viking Therapeutics Inc stock price live 13.010, this page displays NASDAQ VKTX stock exchange data. View the VKTX premarket stock price ahead of the market session or assess the after hours quote.Mar. 28, 2023, 08:37 AM. Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of ...Dec 1, 2023 · According to the issued ratings of 9 analysts in the last year, the consensus rating for Viking Therapeutics stock is Buy based on the current 9 buy ratings for VKTX. The average twelve-month price prediction for Viking Therapeutics is $30.25 with a high price target of $37.00 and a low price target of $19.00. XBI, TGTX, VKTX, NVAX: Large Outflows Detected at ETF. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P ...Get the latest Viking Therapeutics, Inc VKTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... NASDAQ data is at least 15 minutes delayed.Viking Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VKTX updated stock price target summary.Price Volume Sep '23 Oct '23 Nov '23 Dec '23 $10 $8 $12 $14 $16 $18 0M 10M 20M 2020. Display Events. Dividends. Splits. Earnings. News. Chart Style. Line. Mountain.In the news. Yahoo Finance. 3 days ago. Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 74% of the company.

NASDAQ:VKTX Viking Therapeutics (VKTX) Stock Forecast & Price Target $11.56 +0.21 (+1.85%) (As of 11/22/2023 ET) Compare Today's Range $11.21 $11.68 50 …

Please enter a valid Stock, ETF, Mutual Fund, or index symbol. Recent research: Viking Therapeutics Inc. Viking Therapeutics Inc VKTX:NASDAQ. Last Price ...

If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock. SAN DIEGO , March 29, 2023 /PRNewswire/ -- Viking Therapeutics, …Clinical-stage biotech Viking Therapeutics (NASDAQ:VKTX) added 15% on Monday after Roche (OTCQX:RHHBY) agreed to acquire a peer obesity drugmaker Carmot …VIX 12.64 -2.17% -0.28 Home VKTX • NASDAQ Viking Therapeutics Inc Follow Share $12.85 Dec 1, 2:40:54 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Madrigal Pharmaceuticals Inc $207.41...SVB Securities analyst Thomas Smith maintained a Buy rating on Viking Therapeutics (VKTX - Research Report) on October 26 and set a price target o... SVB Securities analyst Thomas Smith maintained a Buy rating on Viking Therapeutics (VKTX -...Nov 28, 2023 · See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Find the latest Earnings Report Date for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. Nasdaq Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access ...

Viking Therapeutics (NASDAQ:VKTX) is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders ...VKTX Related ETFs ; VTI, 0%, +3.43% ; Total Stock Market ETF Vanguard ; DWAS, 0.82%, -2.47% ; DWA Smallcap Momentum Invesco ETF ...View real-time VKTX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ... Instagram:https://instagram. non woke investment firmscnrg etfcan i make money in forex tradingtesla stock drops Rhumbline Advisers acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the second quarter, according to its most recent …Clinical-stage biotech Viking Therapeutics (NASDAQ:VKTX) added 15% on Monday after Roche (OTCQX:RHHBY) agreed to acquire a peer obesity drugmaker Carmot Therapeutics (CRMO) in a up to $3.1B deal ... unlock mortgage reviewsrefinance usda to conventional Shares of NASDAQ VKTX opened at $13.01 on Monday. Viking Therapeutics has a 12 month low of $3.54 and a 12 month high of $25.72. The stock has a 50 day moving average of $10.86 and a 200-day ...The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023. The analyst firm set a price target ... fidelity select technology VKTX soared on obesity data, while Incyte INCY suffered a setback for ruxolitinib extended-release ... The Nasdaq Biotechnology Index has gained 0.68% in the past five trading sessions. Among the ...See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Viking Therapeutics, Inc. Common Stock (VKTX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.